Innovative Biopharmaceuticals

Innovative first-generation biopharmaceuticals

Biopartners’ aim is to be a leader in developing and commercializing biopharmaceuticals for which there are substantial unmet patients/medical needs. This strategy involves bringing to market both innovative formulations and/or novel delivery systems of first-generation biopharmaceuticals.

Products

• Sustained Release Recombinant Human Growth Hormone (SR-rhGH) Once-a-week administration
• Biferonex^® - Interferon Beta